Esperion has entered into a settlement agreement with Dr. Reddy’s to resolve the patent litigation in response to Dr. Reddy’s seeking approval to market a generic version of Nexletol and Nexlizet ...
Pharma shares gained on Thursday, lifted by reports that the US Administration may exclude generic medicines from proposed new import tariffs. The Nifty pharma index climbed 1.05%, with key stocks ...
The pharma sector is in focus and all pharma stocks are surging. This is after a Wall Street Journal report indicated that the Trump administration may not impose tariffs on generic medicines. There ...
The Food and Drug Administration has approved a new generic version of the abortion pill mifepristone, prompting an outcry from conservatives who’ve been eager to restrict access to the medication.
Former Vice President Mike Pence called the decision "a complete betrayal of the pro-life movement that elected President Trump." Mifepristone is used in two-thirds of all abortions in the United ...
With US President Trump, nothing can be ruled out. But, for now at least, Indian pharma companies can breathe a little easier. The 100% tariff shock on pharmaceutical imports into the US from October ...
Independent pharmacists across the U.S. are stockpiling generic drugs as they brace for potential price hikes and supply disruptions following President Donald Trump’s threat to impose an additional ...
As part of the settlement, the parties will file Consent Judgments with the United States Court of Appeals for the Federal Circuit and the United States District Courts for the District of New Jersey ...
Hypera plans to introduce a generic version of semaglutide in Brazil following patent expiration in 2026. The company is optimistic about market growth despite potential price impacts. Analysts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback